Cargando…

Influenza virus exploits tunneling nanotubes for cell-to-cell spread

Tunneling nanotubes (TNTs) represent a novel route of intercellular communication. While previous work has shown that TNTs facilitate the exchange of viral or prion proteins from infected to naïve cells, it is not clear whether the viral genome is also transferred via this mechanism and further, whe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Amrita, Kim, Jin Hyang, Ranjan, Priya, Metcalfe, Maureen G., Cao, Weiping, Mishina, Margarita, Gangappa, Shivaprakash, Guo, Zhu, Boyden, Edward S., Zaki, Sherif, York, Ian, García-Sastre, Adolfo, Shaw, Michael, Sambhara, Suryaprakash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216422/ https://www.ncbi.nlm.nih.gov/pubmed/28059146 http://dx.doi.org/10.1038/srep40360

Ejemplares similares

Influenza Virus Infects and Depletes Activated Adaptive Immune Responders
por: Bohannon, Caitlin D., et al.
Publicado: (2021)

Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI(®) induces enhanced serological, cellular and protective immune responses
por: Cao, Weiping, et al.
Publicado: (2018)

A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018)

A Dual-Functioning 5ʹ-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1
por: Singh, Neetu, et al.
Publicado: (2020)

Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival
por: De La Cruz, Juan A., et al.
Publicado: (2021)

Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice
por: Cao, Weiping, et al.
Publicado: (2017)

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses
por: Hassan, Ahmed O., et al.
Publicado: (2017)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in Mice
por: Hofstetter, Amelia R., et al.
Publicado: (2016)

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication
por: Ranjan, Priya, et al.
Publicado: (2010)

The 3′ Untranslated Regions of Influenza Genomic Sequences Are 5′PPP-Independent Ligands for RIG-I
por: Davis, William G., et al.
Publicado: (2012)

Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation
por: Sharma, Kulbhushan, et al.
Publicado: (2011)

Mycoplasma exploits mammalian tunneling nanotubes for cell-to-cell dissemination
por: Kim, Bong-Woo, et al.
Publicado: (2019)

Innate lymphoid cells (ILC) in SARS-CoV-2 infection()
por: Kumar, Amrita, et al.
Publicado: (2021)

Leishmania donovani Exploits Tunneling Nanotubes for Dissemination and Propagation of B Cell Activation
por: Stögerer, Tanja, et al.
Publicado: (2023)

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial
por: Gaglani, Manjusha, et al.
Publicado: (2022)

Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020
por: Naleway, Allison L, et al.
Publicado: (2023)

Immunosenescence and Influenza Vaccine Efficacy
por: Sambhara, Suryaprakash, et al.
Publicado: (2009)

Increased MDSC Accumulation and Th2 Biased Response to Influenza A Virus Infection in the Absence of TLR7 in Mice
por: Jeisy-Scott, Victoria, et al.
Publicado: (2011)

Inception Mechanisms of Tunneling Nanotubes
por: Drab, Mitja, et al.
Publicado: (2019)

Discovery of Retro-1 Analogs Exhibiting Enhanced Anti-vaccinia Virus Activity
por: Priyamvada, Lalita, et al.
Publicado: (2020)

Tunneling into resistive multiwalled carbon nanotubes
por: Tarkiainen, R., et al.
Publicado: (2001)

Tunneling nanotubes: Diversity in morphology and structure
por: Austefjord, Magnus Wiger, et al.
Publicado: (2014)

Tunneling Nanotubes and Tumor Microtubes in Cancer
por: Roehlecke, Cora, et al.
Publicado: (2020)

Role of Tunneling Nanotubes in the Nervous System
por: Tarasiuk, Olga, et al.
Publicado: (2022)

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
por: Li, Athena P. Y., et al.
Publicado: (2021)

Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins
por: Batra, Jyoti, et al.
Publicado: (2016)

Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Multifaceted Roles of Tunneling Nanotubes in Intercellular Communication
por: Marzo, Ludovica, et al.
Publicado: (2012)

Tunneling-nanotube direction determination in neurons and astrocytes
por: Sun, X, et al.
Publicado: (2012)

Effect of tolytoxin on tunneling nanotube formation and function
por: Dilsizoglu Senol, Aysegul, et al.
Publicado: (2019)

Tunneling nanotubes and actin cytoskeleton dynamics in glaucoma
por: Keller, Kate E.
Publicado: (2020)

Intercellular Communication in the Brain through Tunneling Nanotubes
por: Khattar, Khattar E., et al.
Publicado: (2022)

Tunneling Nanotubes: A New Target for Nanomedicine?
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples
por: Realegeno, Susan, et al.
Publicado: (2018)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020)

Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
por: Elkashif, Ahmed, et al.
Publicado: (2021)

The art of cellular communication: tunneling nanotubes bridge the divide
por: Gurke, Steffen, et al.
Publicado: (2008)

InAs/Si Hetero-Junction Nanotube Tunnel Transistors
por: Hanna, Amir N., et al.
Publicado: (2015)

Tunneling Nanotubes: Intimate Communication between Myeloid Cells
por: Dupont, Maeva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2o9scl7j5k1ko4m9nn40cmrirc